Bausch Health Companies BHC
NYSE BHC
$6.84 -0.05 (-0.65%)
At close: Aug 20, 2026 · 2:02 PM UTC

Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)

Bausch Health Companies (BHC) posted Other Non Operating Income of -$7.0 million for Q2 2026, up 36.36% sequentially from -$11.0 million in Q1 2026, and down 103.93% YoY from $178.0 million in Q2 2025.

Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Other Non Operating Income for 18 years, with the latest figure at -$7.0 million in Q2 2026.

  • Quarterly Other Non Operating Income fell 103.93% year-over-year to -$7.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$44.0 million (down 128.76% YoY) and the FY2025 annual result came in at $162.0 million, up 444.68% from the prior year.
  • Other Non Operating Income rose to -$7.0 million in Q2 2026 per BHC's latest filing, from -$11.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $570.0 million in Q3 2022 and troughed at -$21.0 million in Q2 2023.
  • A 5-year average of $65.5 million and a median of -$7.0 million in 2022 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2022 and 2024: Other Non Operating Income surged 4850.0% in 2022, then plunged 2200.0% in 2024.
  • Over 5 years, Other Non Operating Income stood at $369.0 million in 2022, then sank by 99.73% to $1.0 million in 2023, then slumped by 2200.0% to -$21.0 million in 2024, then climbed by 9.52% to -$19.0 million in 2025, then soared by 63.16% to -$7.0 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$7.0 million, -$11.0 million, and -$19.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Bausch Health Companies 2.57 Bn 728.87 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -11.00 Mn
Sep 30, 2025 -7.00 Mn
Jun 30, 2025 -30.00 Mn
Dec 31, 2024 49.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -15.00 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 -7.00 Mn
Jun 30, 2023 10.00 Mn
Mar 31, 2023 -10.00 Mn
Dec 31, 2022 369.00 Mn
Sep 30, 2022 570.00 Mn
Jun 30, 2022 113.00 Mn
Mar 31, 2022 -7.00 Mn
Dec 31, 2021 -4.00 Mn
Sep 30, 2021 -12.00 Mn
Jun 30, 2021 7.00 Mn
Mar 31, 2021 1.00 Mn